Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07058415

Impact of Three Probabilistic Antibiotic Therapy on Digestive Microbiota and Colonization With Multi-resistant Bacteria

Osteoarticular Infections on Equipment: Impact of Three Probabilistic Antibiotic Therapy on Digestive Microbiota and Colonization With Multi-resistant Bacteria

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
75 (estimated)
Sponsor
Centre Hospitalier Universitaire de Nice · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In the event of suspected osteoarticular material infection (OAMI), broad-spectrum probabilistic antibiotic therapy is recommended immediately after revision surgery. There are no efficacy data to suggest that any particular to favour any particular molecule. However, the choice may depend on the impact on the microbiota and on Enterobacteriaceae colonization with multi-resistant Enterobacteriaceae. Our aim is to evaluate three different strategies efepime+daptomycin C+D, piperacillin-tazobactam+daptomycin (PT+D) and ceftobiprole (CFB).

Conditions

Interventions

TypeNameDescription
OTHERStool sample 1Stool sampling at D0 for having baseline reference
OTHERStool sample 2Stool sampling at D5 to study the impact of antibiotics on microbiota
OTHERStool sample 3Stool sampling at DX+28 to study the impact of antibiotics on microbiota

Timeline

Start date
2025-09-01
Primary completion
2027-05-01
Completion
2027-05-01
First posted
2025-07-10
Last updated
2025-07-10

Locations

4 sites across 1 country: France

Source: ClinicalTrials.gov record NCT07058415. Inclusion in this directory is not an endorsement.